Featured Image for Rancho BioSciences, LLC
Rancho Biosciences Wins NINDS NeuroBioBank Award to Integrate Neuropathological Data
August 30, 2022 08:00 ET | Rancho BioSciences, LLC
SAN DIEGO, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Rancho Biosciences, the leading company in the field of life science data curation and data services, is pleased to announce they have been awarded a...
researchdrivelogo.jpg
Global Neuromonitoring Devices Market Expected to Surpass $10,276.0 Million and Grow at 7.24% CAGR in 2022-2030 [210-Pages] | Declared by Research Dive
May 31, 2022 09:05 ET | Research Dive
New York, USA, May 31, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global neuromonitoring devices market is estimated to gather a revenue of $10,276.0 million by...
researchdrivelogo.jpg
Medical Tourism Market Projected to Garner a Revenue of $149.34 Billion by 2026, Growing at a CAGR of 12.4% from 2019-2026 [140-Pages] | Reveals by Research Dive
December 08, 2021 09:00 ET | Research Dive
New York, USA, Dec. 08, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to garner a revenue of $149.34 billion by 2026 and...
researchdrivelogo.jpg
Global Medical Tourism Market Anticipated to Garner Significant Revenue of $149.34 Billion by 2026 at a stable CAGR of 12.4% from 2019-2026 - Exclusive Report [140-Pages] by Research Dive
September 22, 2021 09:00 ET | Research Dive
New York, USA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- As per the latest report published by Research Dive, the global medical tourism market is predicted to witness a significant rise in revenue...
researchdrivelogo.jpg
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
September 14, 2021 09:01 ET | Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
brsf.png
Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset
March 12, 2021 08:30 ET | Brain Scientific Inc.
NEW YORK, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF ) today announces it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that...
brsf.png
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
December 15, 2020 08:30 ET | Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
Logo.png
Ozop Surgical Completes Merger, Announces New Name
June 29, 2020 08:30 ET | Ozop Surgical Corp.
Ozop Surgical will become Ozop Energy Solutions to reflect new strategy WARWICK, NY., June 29, 2020 (GLOBE NEWSWIRE) -- Ozop Surgical Corp. (OZSC), (“Ozop” or the “Company”), is pleased to...
Logo.png
National PR Firm Gregory FCA Named Agency of Record for OZOP Surgical
June 11, 2020 15:15 ET | Ozop Surgical Corp.
WARWICK, NY., June 11, 2020 (GLOBE NEWSWIRE) -- Ozop Surgical Corp. (OZSC), (“Ozop” or the “Company”), today announced it has engaged Gregory FCA as its public relations agency of record. This new...
Logo.png
OZSC: Power Conversion Technologies, Inc. Recently Received PO from Company In Major Asian Conglomerate Group
May 18, 2020 08:30 ET | Ozop Surgical Corp.
WARWICK, NY, May 18, 2020 (GLOBE NEWSWIRE) -- Ozop Surgical Corp. (OTCPK: OZSC), (“Ozop” or the “Company”), today announces that Power Conversion Technologies, Inc. (“PCTI”), has recently received a...